Prostacom

Prostacom may be available in the countries listed below.

Ingredient matches for Prostacom

Finasteride

Finasteride is reported as an ingredient of Prostacom in the following countries:

• Indonesia

International Drug Name Search

Amiodar

Amiodar may be available in the countries listed below.

Ingredient matches for Amiodar

Amiodarone

Amiodarone hydrochloride (a derivative of Amiodarone) is reported as an ingredient of Amiodar in the following countries:

• Italy


• Myanmar


• Sri Lanka


• Switzerland

International Drug Name Search

Tryptanol

Tryptanol may be available in the countries listed below.

Ingredient matches for Tryptanol

Amitriptyline

Amitriptyline hydrochloride (a derivative of Amitriptyline) is reported as an ingredient of Tryptanol in the following countries:

• Argentina


• Brazil


• Japan


• Mexico


• South Africa


• Taiwan


• Venezuela

International Drug Name Search

Duratuss AC 12 Suspension

Pronunciation: FEN-il-EF-rin/DYE-fen-HYE-dra-meen/DEX-troe-meth-OR-fan
Generic Name: Phenylephrine/Diphenhydramine/Dextromethorphan
Brand Name: Duratuss AC 12

Duratuss AC 12 Suspension is used for:

Relieving symptoms of sinus congestion, runny nose, sneezing, and cough due to colds, upper respiratory infections, and allergies. It may also be used for other conditions as determined by your doctor.

Duratuss AC 12 Suspension is a decongestant, antihistamine, and cough suppressant combination. It works by constricting blood vessels and reducing swelling in the nasal passages. The antihistamine works by blocking the action of histamine, which helps reduce symptoms such as watery eyes and sneezing. The cough suppressant works in the brain to help decrease the cough reflex to reduce a dry cough.

Do NOT use Duratuss AC 12 Suspension if:

• you are allergic to any ingredient in Duratuss AC 12 Suspension


• you have severe high blood pressure, severe heart blood vessel disease, rapid heartbeat, severe heart problems, stomach ulcer, or narrow-angle glaucoma


• you are unable to urinate or are having an asthma attack


• you take sodium oxybate (GHB) or you have taken furazolidone or a monoamine oxidase inhibitor (MAOI) (eg, phenelzine) within the last 14 days

Contact your doctor or health care provider right away if any of these apply to you.

Before using Duratuss AC 12 Suspension:

Some medical conditions may interact with Duratuss AC 12 Suspension. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you have a fast, slow, or irregular heartbeat


• if you have a history of adrenal gland problems (eg, adrenal gland tumor); heart problems; high blood pressure; diabetes; heart blood vessel problems; stroke; glaucoma; a blockage of your stomach, bladder, or intestines; ulcers; trouble urinating; an enlarged prostate or other prostate problems; seizures; mental or mood problems (eg, depression); or an overactive thyroid


• if you have a history of asthma, chronic cough, lung problems (eg, chronic bronchitis, emphysema), or chronic obstructive pulmonary disease (COPD), or if your cough occurs with large amounts of mucus


• if you are in poor health or are very overweight

Some MEDICINES MAY INTERACT with Duratuss AC 12 Suspension. Tell your health care provider if you are taking any other medicines, especially any of the following:

• Digoxin or droxidopa because the risk of irregular heartbeat or heart attack may be increased


• Beta-blockers (eg, propranolol), catechol-O-methyltransferase (COMT) inhibitors (eg, tolcapone), furazolidone, indomethacin, MAOIs (eg, phenelzine), sodium oxybate (GHB), or tricyclic antidepressants (eg, amitriptyline) because they may increase the risk of Duratuss AC 12 Suspension's side effects


• Bromocriptine or hydantoins (eg, phenytoin) because the risk of their side effects may be increased by Duratuss AC 12 Suspension


• Guanadrel, guanethidine, mecamylamine, methyldopa, or reserpine because their effectiveness may be decreased by Duratuss AC 12 Suspension

This may not be a complete list of all interactions that may occur. Ask your health care provider if Duratuss AC 12 Suspension may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Duratuss AC 12 Suspension:

Use Duratuss AC 12 Suspension as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• Take Duratuss AC 12 Suspension by mouth with or without food. If stomach upset occurs, take with food to reduce stomach irritation.


• Shake well before each use.


• Use a measuring device marked for medicine dosing. Ask your pharmacist for help if you are unsure of how to measure your dose.


• Drink plenty of water while taking Duratuss AC 12 Suspension.


• If you miss a dose of Duratuss AC 12 Suspension, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Duratuss AC 12 Suspension.

Important safety information:

• Duratuss AC 12 Suspension may cause drowsiness, dizziness, or blurred vision. These effects may be worse if you take it with alcohol or certain medicines. Use Duratuss AC 12 Suspension with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.


• Do not drink alcohol or use medicines that may cause drowsiness (eg, sleep aids, muscle relaxers) while you are using Duratuss AC 12 Suspension; it may add to their effects. Ask your pharmacist if you have questions about which medicines may cause drowsiness.


• Some of these products contain phenylalanine. If you must have a diet that is low in phenylalanine, ask your pharmacist if it is in your product.


• Duratuss AC 12 Suspension has phenylephrine, diphenhydramine, and dextromethorphan in it. Before you start any new medicine, check the label to see if it has phenylephrine, diphenhydramine, or dextromethorphan in it too. If it does or if you are not sure, check with your doctor or pharmacist.


• Do not use Duratuss AC 12 Suspension for a cough with a lot of mucus. Do not use it for a long-term cough (eg, caused by asthma, emphysema, smoking). However, you may use it for these conditions if your doctor tells you to.


• Do NOT take more than the recommended dose or use for longer than prescribed without checking with your doctor.


• If your symptoms do not get better within 5 to 7 days or if they get worse, check with your doctor.


• Duratuss AC 12 Suspension may cause you to become sunburned more easily. Avoid the sun, sunlamps, or tanning booths until you know how you react to Duratuss AC 12 Suspension. Use a sunscreen or wear protective clothing if you must be outside for more than a short time.


• Duratuss AC 12 Suspension may interfere with skin allergy tests. If you are scheduled for a skin test, talk to your doctor. You may need to stop taking Duratuss AC 12 Suspension for a few days before the tests.


• Tell your doctor or dentist that you take Duratuss AC 12 Suspension before you receive any medical or dental care, emergency care, or surgery.


• Use Duratuss AC 12 Suspension with caution in the ELDERLY; they may be more sensitive to its effects, especially dizziness or drowsiness.


• Duratuss AC 12 Suspension should be used with extreme caution in CHILDREN younger than 2 years old; safety and effectiveness in these children have not been confirmed.


• Caution is advised when using Duratuss AC 12 Suspension in CHILDREN; they may be more sensitive to its effects, especially excitability.


• PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Duratuss AC 12 Suspension while you are pregnant. It is not known if Duratuss AC 12 Suspension is found in breast milk. Do not breast-feed while taking Duratuss AC 12 Suspension.

Possible side effects of Duratuss AC 12 Suspension:

All medicines may cause side effects, but many people have no, or minor side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Blurred vision; constipation; diarrhea; dizziness; drowsiness; dry mouth, nose, or throat; excitability; headache; increased sweating; loss of appetite; nausea; nervousness or anxiety; trouble sleeping; upset stomach; vomiting; weakness.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); difficulty urinating or inability to urinate; fast or irregular heartbeat; fever, chills, or sore throat; flushing or redness of the face; hallucinations; mental or mood changes; numbness or tingling; seizures; severe dizziness, drowsiness, lightheadedness, or headache; severe dryness of mouth, nose, and throat; shortness of breath; tremor; trouble sleeping; unusual bruising or bleeding; vision changes; wheezing.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Duratuss AC2 side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include blurred vision; confusion; hallucinations; muscle spasms; seizures; severe dizziness, lightheadedness, or headache; severe drowsiness; unusual eye movements; unusually fast, slow, or irregular heartbeat; vomiting.

Proper storage of Duratuss AC 12 Suspension:

Store Duratuss AC 12 Suspension at room temperature, between 68 and 77 degrees F (20 and 25 degrees C). Do not freeze. Store away from heat, moisture, and light. Do not store in the bathroom. Keep Duratuss AC 12 Suspension out of the reach of children and away from pets.

General information:

• If you have any questions about Duratuss AC 12 Suspension, please talk with your doctor, pharmacist, or other health care provider.


• Duratuss AC 12 Suspension is to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Duratuss AC 12 Suspension. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Duratuss AC 12 resources

• Duratuss AC 12 Side Effects (in more detail)
• Duratuss AC 12 Use in Pregnancy & Breastfeeding
• Duratuss AC 12 Drug Interactions
• Duratuss AC 12 Support Group
• 0 Reviews for Duratuss AC2 - Add your own review/rating

Compare Duratuss AC 12 with other medications

• Cold Symptoms
• Cough and Nasal Congestion
• Hay Fever
• Sinusitis

Alganex

Alganex may be available in the countries listed below.

Ingredient matches for Alganex

Tenoxicam

Tenoxicam is reported as an ingredient of Alganex in the following countries:

• Sweden

International Drug Name Search

Flurandrenolide

Flurandrenolide may be available in the countries listed below.

Ingredient matches for Flurandrenolide

Fludroxycortide

Flurandrenolide (USAN) is also known as Fludroxycortide (Rec.INN)

International Drug Name Search

Glossary

Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Torasemide Sodium

Torasemide Sodium may be available in the countries listed below.

Ingredient matches for Torasemide Sodium

Torasemide

Torasemide Sodium (BANM) is also known as Torasemide (Rec.INN)

International Drug Name Search

Glossary

BANM	British Approved Name (Modified)
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Topisept

Topisept may be available in the countries listed below.

Ingredient matches for Topisept

Fusidic Acid

Fusidic Acid is reported as an ingredient of Topisept in the following countries:

• Colombia

International Drug Name Search

Pentoxifylline

In the US, Pentoxifylline (pentoxifylline systemic) is a member of the drug class miscellaneous coagulation modifiers and is used to treat Intermittent Claudication.

US matches:

• Pentoxifylline

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

C04AD03

CAS registry number (Chemical Abstracts Service)

0006493-05-6

Chemical Formula

C13-H18-N4-O3

Molecular Weight

278

Therapeutic Category

Vasodilator, peripheric

Chemical Name

1H-Purine-2,6-dione, 3,7-dihydro-3,7-dimethyl-1-(5-oxohexyl)-

Foreign Names

• Pentoxifyllinum (Latin)
• Pentoxifyllin (German)
• Pentoxifylline (French)
• Pentoxifilina (Spanish)

Generic Names

• Oxpentifylline (OS: BAN)
• Pentoxifillina (OS: DCIT)
• Pentoxifylline (OS: BAN, JAN, DCF, USAN)
• BL 191 (IS: AlbertRoussel)
• PTX (IS: Sigma)
• Pentoxifyllin (PH: Ph. Eur. 6)
• Pentoxifylline (PH: BP 2010, JP VIII, USP 32, Ph. Eur. 6)
• Pentoxifyllinum (PH: Ph. Eur. 6)

Brand Names

• Agapurin retard
  Zentiva, Bangladesh; Zentiva, Bulgaria; Zentiva, Czech Republic



• Agapurin
  Medphano, Germany; Roemmers, Venezuela; Zentiva, Bulgaria; Zentiva, Czech Republic; Zentiva, Georgia; Zentiva, Lithuania; Zentiva, Latvia; Zentiva, Poland; Zentiva, Romania; Zentiva, Russian Federation; Zentiva, Slovakia



• Angiopent
  Helcor, Romania



• Apo-Pentox
  Apotex, Poland



• Apo-Pentoxifilina
  Apotex, Peru



• Apo-Pentoxifylline
  Apotex, Canada; Apotex, Czech Republic; Apotex, Guyana; Apotex, Vietnam



• Artal
  Ayanda, Finland



• Chinotal
  Pannonpharma, Hungary



• Circulaid
  Saiph, Tunisia



• Claudicat
  Nycomed, Germany; Nycomed, Portugal



• Damaton
  Galenika, Serbia



• Dartelin
  Lek, Bosnia & Herzegowina; Lek, Poland; Lek, Slovenia



• Difusil
  Ivax, Peru



• Dospan-Pento
  Ivax, Argentina



• Duplat
  Degort's, Mexico



• Durapental
  Merck, Peru; Mylan dura, Germany



• Elorgan
  Sanofi-Aventis S.A., Spain



• Fixoten
  Cryopharma, Mexico



• Flexital
  Sun, Myanmar; Sun, Russian Federation



• Hemovas
  Robert, Spain



• Herden
  Remedica, Bahrain; Remedica, Jordan; Remedica, Sudan; Remedica, Yemen



• Kentadin
  Kendrick, Mexico



• Kinetal
  Unifarma, Latvia



• Lentrin
  Metiska, Indonesia



• Nelorpin
  Ferrer, Spain



• Oxifyl
  Square, Bangladesh



• Oxopurin
  Dexxon, Israel



• Pentamon
  Pliva, Croatia (Hrvatska)



• Pentilin Retard
  Krka, Poland



• Pentilin
  Krka, Bosnia & Herzegowina; Krka, Czech Republic; Krka, Estonia; Krka, Croatia (Hrvatska); Krka, Lithuania; Krka, Latvia; Krka, Poland; Krka, Serbia; Krka, Slovenia



• Pentoflux
  Bouchara, France



• Pentofyllin
  Sopharma, Georgia



• PentoHexal
  Hexal, Austria; Hexal, Germany; Hexal, Poland; Salutas Pharma, Serbia



• Pentoksifilin
  Hemofarm, Serbia



• Pentolab
  Lamsa, Argentina



• Pentomer retard
  Ratiopharm, Austria



• Pentomer
  Ratiopharm, Austria; Ratiopharm, Czech Republic



• Pento-Puren
  Actavis, Germany



• Pentox
  Abdi Ibrahim, Turkey; Farmasa, Brazil; Littman, Philippines



• Pentox-CT
  CT, Luxembourg; CT Arzneimittel, Germany



• Pentoxi Genericon retard
  Genericon, Austria



• Pentoxi Genericon
  Genericon, Austria



• Pentoxi Retard
  Terapia, Romania



• Pentoxicux
  TAD, Germany



• Pentoxifilin
  Arena, Romania; Terapia, Romania



• Pentoxifilina Alter
  Alter, Spain



• Pentoxifilina Belmac
  Belmac, Spain



• Pentoxifilina Davur
  Davur, Spain



• Pentoxifilina Generis
  Generis, Portugal



• Pentoxifilina Genfar
  Expofarma, Chile; Genfar, Colombia; Genfar, Ecuador; Genfar, Peru



• Pentoxifilina L.CH.
  Chile, Chile



• Pentoxifilina La Santé
  La Santé, Colombia



• Pentoxifilina MK
  MK, Colombia



• Pentoxifilina
  Biogen, Peru; Genéricos Venezolanos, Venezuela; Kope Trading, Peru; Medicalex, Colombia; Mintlab, Chile; OFA, Venezuela



• Pentoxifyllin AbZ
  AbZ, Germany



• Pentoxifyllin acis
  Acis, Germany



• Pentoxifyllin AL
  Aliud, Czech Republic; Aliud, Germany; Aliud, Hungary



• Pentoxifyllin Basics
  Basics, Germany



• Pentoxifyllin Sandoz
  Sandoz, Germany



• Pentoxifyllin Stada
  Stada, Germany



• Pentoxifyllin
  Actavis, Georgia; Borisov, Georgia; GAMA, Georgia



• Pentoxifyllin-B
  Teva, Hungary



• Pentoxifylline Biogaran
  Biogaran, France



• Pentoxifylline EG
  EG Labo, France



• Pentoxifylline Merck
  Mylan, France



• Pentoxifylline PCH
  Pharmachemie, Netherlands



• Pentoxifylline Qualimed
  Qualimed, France



• Pentoxifylline Ratiopharm
  Ratiopharm, France



• Pentoxifylline RPG
  RPG, France



• Pentoxifylline Sandoz
  Sandoz, France



• Pentoxifylline Teva
  Teva Santé, France



• Pentoxifylline
  Actavis, United States; Biovail, United States; Clonmel, United States; Impax, United States; Karib, Netherlands; Mylan, United States; Pliva, United States; Shreya, Russian Federation; Teva USA, United States; Torpharm, United States; Watson, United States



• Pentoxifylline-1A
  1A Pharma, Poland



• Pentoxifylline-Akri
  Akrihin, Russian Federation



• Pentoxifylline-Teva
  Teva, Israel



• Pentoxifyllin-ratiopharm
  Ratiopharm, Germany; Ratiopharm, Luxembourg; Ratiopharm, Netherlands



• Pentoxifyllinum Biotika
  Biotika, Czech Republic; Biotika, Slovakia; Hoechst-Biotika, Lithuania



• Pentoxil
  Upsher-Smith, United States



• PentoxiMed retard
  S.Med, Austria



• Pentoxi-Mepha
  Mepha Pharma, Switzerland



• Pentoxin
  Ethical, Dominican Republic; Ratiopharm, Finland



• Pentoxiphat LP
  Siphat, Tunisia



• Pentoxy Heumann
  Heumann, Germany



• Pentoxyl-EP
  ExtractumPharma, Hungary



• Perivax R
  Chalver, Peru



• Perivax
  Chalver, Peru



• Pexal
  Mepha, Costa Rica; Mepha, Guatemala; Mepha, Honduras; Mepha, Panama; Mepha, El Salvador; Mepha, Trinidad & Tobago



• Pexol
  Mepha, Peru



• Platof
  Sanbe, Indonesia



• Polfilin prolongatum
  Polpharma, Poland



• Polfilin Retard
  polpharma, Vietnam



• Polfilin
  Polpharma, Lithuania; Polpharma, Latvia; Polpharma, Poland; Polpharma, Vietnam



• Previscan
  Investi, Argentina



• ratio-Pentoxifylline
  ratiopharm, Canada



• Rentylin
  Amdipharm, Germany; Shire, Luxembourg



• Reotal
  Kalbe, Indonesia



• Retimax
  Alcon, Spain



• Sufisal
  Silanes, Dominican Republic; Silanes, Guatemala; Silanes, Honduras; Silanes, Mexico; Silanes, Nicaragua; Silanes, El Salvador



• Tarontal
  Bernofarm, Indonesia; Sanofi-aventis, Greece



• Tioxad
  Fahrenheit, Indonesia



• Tirentall
  GAMA, Georgia



• Torental
  Aventis, Luxembourg; Aventis, Tunisia; Sanofi-Aventis, Belgium; Sanofi-Aventis, France; Winthrop, Tunisia



• Trenat
  Interbat, Indonesia



• Trenlin
  CCM Pharma, Singapore



• Trental
  Aventis, Bulgaria; Aventis, Brazil; Aventis, Czech Republic; Aventis, India; Aventis, Iceland; Aventis, Sri Lanka; Aventis, Peru; Aventis, Slovenia; Aventis, South Africa; Hoechst, Oman; Jugoremedija, Serbia; Sanofi Aventis, Antigua & Barbuda; Sanofi Aventis, Netherlands Antilles; Sanofi Aventis, Aruba; Sanofi Aventis, Barbados; Sanofi Aventis, Bermuda; Sanofi Aventis, Bahamas; Sanofi Aventis, Guyana; Sanofi Aventis, Haiti; Sanofi Aventis, Jamaica; Sanofi Aventis, Cayman Islands; Sanofi Aventis, Saint Lucia; Sanofi Aventis, Trinidad & Tobago; Sanofi Aventis, Saint Vincent & The Grenadines; Sanofi-Aventis, Argentina; Sanofi-Aventis, Austria; Sanofi-Aventis, Australia; Sanofi-Aventis, Bangladesh; Sanofi-Aventis, Bulgaria; Sanofi-Aventis, Bulgaria; Sanofi-Aventis, Canada; Sanofi-Aventis, Switzerland; Sanofi-Aventis, Chile; Sanofi-Aventis, Colombia; Sanofi-Aventis, Costa Rica; Sanofi-Aventis, Germany; Sanofi-Aventis, Denmark; Sanofi-Aventis, Dominican Republic; Sanofi-Aventis, Ecuador; Sanofi-Aventis, Estonia; Sanofi-Aventis, Finland; Sanofi-Aventis, United Kingdom; Sanofi-Aventis, Georgia; Sanofi-Aventis, Guatemala; Sanofi-Aventis, Hong Kong; Sanofi-Aventis, Honduras; Sanofi-Aventis, Croatia (Hrvatska); Sanofi-Aventis, Hungary; Sanofi-Aventis, Indonesia; Sanofi-Aventis, Ireland; Sanofi-Aventis, Israel; Sanofi-Aventis, Italy; Sanofi-Aventis, Lithuania; Sanofi-Aventis, Latvia; Sanofi-Aventis, Malta; Sanofi-Aventis, Mexico; Sanofi-Aventis, Malaysia; Sanofi-Aventis, Nicaragua; Sanofi-Aventis, Netherlands; Sanofi-Aventis, Norway; Sanofi-Aventis, New Zealand; Sanofi-Aventis, Panama; Sanofi-Aventis, Poland; Sanofi-Aventis, Romania; Sanofi-Aventis, Russian Federation; Sanofi-Aventis, Singapore; Sanofi-Aventis, Slovakia; Sanofi-Aventis, El Salvador; Sanofi-Aventis, Thailand; Sanofi-Aventis, Turkey; Sanofi-Aventis, Taiwan; Sanofi-Aventis, United States; Sanofi-Aventis, Venezuela; Sanofi-Aventis - Produtos farmacêuticos, S.A., Portugal



• Trentilin
  Santa-Farma, Georgia; Santa-Farma, Turkey



• Trentox
  Ferron, Indonesia



• Trenxy
  Danpac Pharma, Indonesia



• Tri-Plen (Pentoxifylline and Felodipine)
  Sanofi-Aventis, South Africa



• Vantoxyl
  Bruluart, Mexico



• Vasonit retard
  Lannacher, Austria



• Vasonit
  Lannacher, Austria; Lannacher, Czech Republic; Lannacher, Estonia; Lannacher, Georgia; Lannacher, Lithuania; Lannacher, Latvia; Schwarz, Russian Federation



• Xipen
  Best, Mexico

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
DCIT	Denominazione Comune Italiana
IS	Inofficial Synonym
JAN	Japanese Accepted Name
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Naproxen Lagap

Naproxen Lagap may be available in the countries listed below.

Ingredient matches for Naproxen Lagap

Naproxen

Naproxen is reported as an ingredient of Naproxen Lagap in the following countries:

• Netherlands

International Drug Name Search

omeprazole

oh-MEP-ra-zole

Commonly used brand name(s)

In the U.S.

• Prilosec


• Prilosec OTC

Available Dosage Forms:

• Tablet, Delayed Release


• Capsule, Delayed Release


• Packet

Pharmacologic Class: Proton Pump Inhibitor

Uses For omeprazole

Omeprazole is used to treat certain conditions where there is too much acid in the stomach. It is used to treat gastric and duodenal ulcers, erosive esophagitis, and gastroesophageal reflux disease (GERD). GERD is a condition where the acid in the stomach washes back up into the esophagus. Sometimes omeprazole is used in combination with antibiotics (e.g., amoxicillin, clarithromycin) to treat ulcers associated with infection caused by the H. pylori bacteria (germ).

Omeprazole is also used to treat Zollinger-Ellison syndrome, a condition where the stomach produces too much acid.

Omeprazole is also used to treat dyspepsia, a condition that causes sour stomach, belching, heart burn, or indigestion.

In addition, omeprazole is used to prevent upper gastrointestinal tract bleeding in seriously ill patients.

Omeprazole is a proton pump inhibitor (PPI). It works by decreasing the amount of acid produced by the stomach.

omeprazole is available both over-the-counter (OTC) and with your doctor's prescription.

Before Using omeprazole

In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For omeprazole, the following should be considered:

Allergies

Tell your doctor if you have ever had any unusual or allergic reaction to omeprazole or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

Pediatric

Appropriate studies performed to date have not demonstrated pediatric-specific problems that would limit the usefulness of omeprazole in children 1 to 16 years of age. Safety and efficacy have not been established in children younger than 1 year of age. .

Geriatric

Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of omeprazole in the elderly.

Pregnancy

	Pregnancy Category	Explanation
All Trimesters	C	Animal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women.

Breast Feeding

There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.

Interactions with Medicines

Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking omeprazole, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.

Using omeprazole with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the other medicines you take.

• Rilpivirine

Using omeprazole with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.

• Atazanavir


• Bendamustine


• Citalopram


• Clopidogrel


• Clorazepate


• Dasatinib


• Delavirdine


• Erlotinib


• Indinavir


• Methotrexate


• Mycophenolate Mofetil


• Nelfinavir


• Nilotinib

Using omeprazole with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.

• Armodafinil


• Carbamazepine


• Cilostazol


• Cranberry


• Digoxin


• Disulfiram


• Fluconazole


• Ginkgo Biloba


• Iron


• Raltegravir


• Saquinavir


• St John's Wort


• Tipranavir


• Triazolam


• Voriconazole


• Warfarin

Interactions with Food/Tobacco/Alcohol

Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.

Other Medical Problems

The presence of other medical problems may affect the use of omeprazole. Make sure you tell your doctor if you have any other medical problems, especially:

• Hypomagnesemia (low magnesium in the blood), history of or


• Osteoporosis (bone problem) or


• Seizures, history of—Use with caution. May make these conditions worse.

• Liver disease—Use with caution. The effects may be increased because of slower removal of the medicine from the body.

Proper Use of omeprazole

Take omeprazole only as directed by your doctor. Do not take more of it, do not take it more often, and do not take it for a longer time than your doctor ordered. If you are using omeprazole without a prescription, follow the instructions on the medicine label.

Take omeprazole capsules or delayed-release capsules before a meal, preferably in the morning. Omeprazole tablets may be taken with food or on an empty stomach. Take omeprazole powder for oral suspension on an empty stomach at least 1 hour before a meal. For patients receiving continuous feeding through a tube, feeding should be temporarily stopped about 3 hours before and 1 hour after administration of omeprazole powder for oral suspension.

It may take several days before omeprazole begins to relieve stomach pain. To help relieve this pain, antacids may be taken with omeprazole, unless your doctor has told you not to use them.

If you are taking omeprazole to treat an ulcer that is associated with an H. pylori infection, take it together with the antibiotics (e.g., amoxicillin, clarithromycin) at the same time of day.

Swallow the capsule and tablet forms of omeprazole whole. Do not open the capsule. Do not crush, break, or chew the capsule or the tablet.

If you cannot swallow the omeprazole delayed-release capsules, you may open it and sprinkle the pellets contained in the capsule on one tablespoon of applesauce. This mixture must be swallowed immediately with a glass of cool water. The applesauce should not be hot and should be soft enough to be swallowed without chewing. Do not chew or crush the pellets.

To use the powder for oral suspension:

• Empty packet of powder into a small cup containing 2 tablespoons of water.


• Do not use other liquids or foods.


• Stir well and drink immediately.


• Refill cup with water and drink.

To use the delayed-release oral suspension:

• Empty the contents of a 2.5 milligrams (mg) packet of powder into a container containing 5 mL of water.


• Empty the contents of a 10 mg packet of powder into a container containing 15 mL of water.


• Do not use other liquids or foods.


• Stir and leave it for 2 to 3 minutes to thicken.


• Stir well and drink within 30 minutes.


• If any medicine remains after drinking, add more water, stir, and drink immediately.

If you are using the delayed-release oral suspension with a nasogastric or gastric tube:

• Add 5 mL to a catheter tipped syringe and then add the contents of a 2.5 mg packet (or 15 mL of water for the 10 mg packet).


• Shake the syringe right away and leave it for 2 to 3 minutes to thicken.


• Shake the syringe and give the medicine through the nasogastric or gastric tube into the stomach with 30 minutes.


• Refill the syringe with an equal amount of water.


• Shake and flush any remaining contents from the nasogastric or gastric tube into the stomach.

Dosing

The dose of omeprazole will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of omeprazole. If your dose is different, do not change it unless your doctor tells you to do so.

The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.

• For oral dosage forms (capsules, delayed-release capsules or suspension, or tablets):
  
  • To treat duodenal ulcers:
    
    • Adults—20 milligrams (mg) once a day before a meal. Your doctor may adjust your dose if needed.
    
    
    • Children—Use and dose must be determined by your doctor.
    
    
  
  
  • To treat duodenal ulcers with H. pylori:
    
    • Adults—20 or 40 milligrams (mg) one or two times a day before a meal. The dose is usually taken together with clarithromycin or clarithromycin plus amoxicillin. Your doctor may adjust your dose if needed.
    
    
    • Children—Use and dose must be determined by your doctor.
    
    
  
  
  • To treat erosive esophagitis:
    
    • Adults—20 milligrams (mg) once a day before a meal. Your doctor may adjust your dose if needed.
    
    
    • Children—Use and dose must be determined by your doctor.
    
    
  
  
  • To treat gastric ulcers:
    
    • Adults—40 milligrams (mg) once a day before a meal. Your doctor may adjust your dose if needed.
    
    
    • Children—Use and dose must be determined by your doctor.
    
    
  
  
  • To treat gastroesophageal reflux disease (GERD):
    
    • Adults—20 milligrams (mg) once a day before a meal. Your doctor may tell you to take 40 mg a day for certain conditions. Also, your doctor may want you to take omeprazole for more than 8 weeks for certain conditions.
    
    
    • Children 1 year of age and older—Dose is based on body weight and must be determined by your doctor. The dose is usually 5 to 20 mg once a day before a meal.
    
    
    • Children younger than 1 year of age—Use and dose must be determined by your doctor.
    
    
  
  
  • To treat Zollinger-Ellison syndrome:
    
    • Adults—60 milligrams (mg) once a day before a meal. Your doctor may adjust your dose if needed.
    
    
    • Children—Use and dose must be determined by your doctor.
    
    
  
  

• For oral dosage forms (powder for suspension):
  
  • To prevent upper gastrointestinal tract bleeding in seriously ill patients:
    
    • Adults—The first day: 40 milligrams (mg) for the first dose; then after 6 to 8 hours, a second 40 mg dose. After the first day: 40 mg once a day for up to 14 days.
    
    
    • Children—Use and dose must be determined by your doctor.
    
    
  
  
  • To treat duodenal ulcer:
    
    • Adults—20 milligrams (mg) once a day for 4 to 8 weeks.
    
    
    • Children—Use and dose must be determined by your doctor.
    
    
  
  
  • To treat gastric ulcers:
    
    • Adults—40 milligrams (mg) once a day for 4 to 8 weeks.
    
    
    • Children—Use and dose must be determined by your doctor.
    
    
  
  
  • To treat gastroesophageal reflux disease (GERD) for erosive esophagitis:
    
    • Adults—20 milligrams (mg) once a day for 4 to 8 weeks.
    
    
    • Children—Use and dose must be determined by your doctor.
    
    
  
  

Missed Dose

If you miss a dose of omeprazole, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.

Storage

Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.

Keep out of the reach of children.

Do not keep outdated medicine or medicine no longer needed.

Ask your healthcare professional how you should dispose of any medicine you do not use.

Precautions While Using omeprazole

It is important that your doctor check the progress of you or your child at regular visits. This will allow your doctor to see if the medicine is working properly and to decide if you should continue to take it. Blood tests may be needed to check for unwanted effects. If your or your child's condition does not improve, or if it becomes worse, check with your doctor.

Tell your doctor if you or your child have Asian relatives, such as Filipino, Chinese, Japanese, Korean, or Taiwanese. You may need a lower dose of omeprazole to treat erosive esophagitis.

omeprazole is sometimes given together with other medicines to treat ulcers. Be sure you understand about the risks and proper use of any other medicine your doctor gives you or your child together with omeprazole.

Omeprazole may cause a serious type of allergic reaction when used in patients with conditions treated with antibiotics. Call your doctor right away if you or your child have itching; trouble breathing or swallowing; or any swelling of your hands, face, or mouth while you or your child are using omeprazole.

Serious stomach conditions may occur while taking omeprazole with antibiotics. Stop using omeprazole and check with your doctor immediately if you or your child are having more than one of these symptoms: abdominal or stomach cramps, bloated feeling, watery and severe diarrhea which may also be bloody sometimes, fever, nausea or vomiting, unusual tiredness or weakness.

omeprazole may increase your risk of having fractures of the hip, wrist, and spine. This is more likely if you are 50 years of age and older, if you receive high doses of omeprazole, or use it for one year or more.

omeprazole may cause hypomagnesemia (low magnesium in the blood). This is more likely to occur if you are taking omeprazole for more than one year, or if you are taking omeprazole together with digoxin (Lanoxin®) or certain diuretics or "water pills". Stop using omeprazole and check with your doctor right away if you have convulsions (seizures); fast, racing, or uneven heartbeat; muscle spasms (tetany); tremors; or unusual tiredness or weakness.

Do not stop taking omeprazole without first checking with your doctor, or unless told to do so by your doctor.

Do not take other medicines unless they have been discussed with your doctor. This includes prescription or nonprescription (over-the-counter [OTC]) medicines and herbal or vitamin supplements.

omeprazole Side Effects

Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur:

Rare

• Back, leg, or stomach pain


• bleeding or crusting sores on the lips


• blisters


• bloody or cloudy urine


• chills


• continuing ulcers or sores in the mouth


• difficult, burning, or painful urination


• fever


• frequent urge to urinate


• general feeling of discomfort or illness


• joint pain


• loss of appetite


• muscle aches or cramps


• pain


• red or irritated eyes


• redness, tenderness, itching, burning, or peeling of the skin


• skin rash or itching


• sore throat


• sores, ulcers, or white spots on the lips, in the mouth, or on the genitals


• unusual bleeding or bruising


• unusual tiredness or weakness

Incidence not known

• Drowsiness


• fast, racing, or uneven heartbeat


• mood or mental changes


• muscle spasms (tetany) or twitching seizures


• nausea or vomiting


• trembling

Get emergency help immediately if any of the following symptoms of overdose occur:

Symptoms of overdose

• Blurred vision


• confusion


• dryness of the mouth


• flushing


• headache


• increased sweating

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Less common

• Body aches or pain


• chest pain


• constipation


• cough


• diarrhea or loose stools


• difficulty with breathing


• dizziness


• ear congestion


• gas


• heartburn


• loss of voice


• muscle pain


• nasal congestion


• runny nose


• sneezing


• unusual drowsiness

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: omeprazole side effects (in more detail)

The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.

The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.

More omeprazole resources

• Omeprazole Side Effects (in more detail)
• Omeprazole Use in Pregnancy & Breastfeeding
• Drug Images
• Omeprazole Drug Interactions
• Omeprazole Support Group
• 46 Reviews for Omeprazole - Add your own review/rating

• Omeprazole Prescribing Information (FDA)


• Omeprazole Professional Patient Advice (Wolters Kluwer)


• Omeprazole Monograph (AHFS DI)


• Omeprazole Delayed-Release Capsules MedFacts Consumer Leaflet (Wolters Kluwer)


• Prilosec Consumer Overview


• Prilosec Prescribing Information (FDA)


• Prilosec OTC Delayed-Release Capsules MedFacts Consumer Leaflet (Wolters Kluwer)

Compare omeprazole with other medications

• Barrett's Esophagus
• Duodenal Ulcer
• Erosive Esophagitis
• GERD
• Helicobacter Pylori Infection
• Indigestion
• Multiple Endocrine Adenomas
• Stomach Ulcer
• Systemic Mastocytosis
• Zollinger-Ellison Syndrome

Eumovate

Eumovate may be available in the countries listed below.

UK matches:

• Eumovate Cream
• Eumovate Eczema & Dermatitis 0.05% Cream (SPC)

Ingredient matches for Eumovate

Clobetasone

Clobetasone 17α-butyrate (a derivative of Clobetasone) is reported as an ingredient of Eumovate in the following countries:

• Argentina


• Bahrain


• Belgium


• Canada


• Chile


• Guyana


• Hong Kong


• Iran


• Ireland


• Israel


• Italy


• Kuwait


• Luxembourg


• Malaysia


• Malta


• New Zealand


• Oman


• Qatar


• Singapore


• South Africa


• Taiwan


• Turkey


• United Arab Emirates


• United Kingdom


• Venezuela


• Vietnam

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Metoprolol GEA Retard

Metoprolol GEA Retard may be available in the countries listed below.

Ingredient matches for Metoprolol GEA Retard

Metoprolol

Metoprolol tartrate (a derivative of Metoprolol) is reported as an ingredient of Metoprolol GEA Retard in the following countries:

• Sweden

International Drug Name Search

Psycholanz

Psycholanz may be available in the countries listed below.

Ingredient matches for Psycholanz

Losartan

Losartan potassium salt (a derivative of Losartan) is reported as an ingredient of Psycholanz in the following countries:

• Myanmar

International Drug Name Search

Hydroform

Hydroform may be available in the countries listed below.

Ingredient matches for Hydroform

Clioquinol

Clioquinol is reported as an ingredient of Hydroform in the following countries:

• Australia

Hydrocortisone

Hydrocortisone is reported as an ingredient of Hydroform in the following countries:

• Australia

International Drug Name Search

Amlodipine Ratiopharm

Amlodipine Ratiopharm may be available in the countries listed below.

Ingredient matches for Amlodipine Ratiopharm

Amlodipine

Amlodipine besilate (a derivative of Amlodipine) is reported as an ingredient of Amlodipine Ratiopharm in the following countries:

• Belgium


• France

Amlodipine maleate (a derivative of Amlodipine) is reported as an ingredient of Amlodipine Ratiopharm in the following countries:

• Netherlands

International Drug Name Search

Pravastatin Streuli

Pravastatin Streuli may be available in the countries listed below.

Ingredient matches for Pravastatin Streuli

Pravastatin

Pravastatin sodium salt (a derivative of Pravastatin) is reported as an ingredient of Pravastatin Streuli in the following countries:

• Switzerland

International Drug Name Search

Maxiliv

Maxiliv may be available in the countries listed below.

Ingredient matches for Maxiliv

Metamizole

Metamizole sodium anhydrous (a derivative of Metamizole) is reported as an ingredient of Maxiliv in the following countries:

• Brazil

International Drug Name Search

Ciprofloxacine Mylan

Ciprofloxacine Mylan may be available in the countries listed below.

Ingredient matches for Ciprofloxacine Mylan

Ciprofloxacin

Ciprofloxacin hydrochloride (a derivative of Ciprofloxacin) is reported as an ingredient of Ciprofloxacine Mylan in the following countries:

• Belgium


• France

International Drug Name Search

Estramustine Sodium Phosphate

Estramustine Sodium Phosphate may be available in the countries listed below.

Ingredient matches for Estramustine Sodium Phosphate

Estramustine

Estramustine Sodium Phosphate (BANM) is known as Estramustine in the US.

International Drug Name Search

Glossary

BANM	British Approved Name (Modified)

Click for further information on drug naming conventions and International Nonproprietary Names.

Homodon

Homodon may be available in the countries listed below.

Ingredient matches for Homodon

Povidone Iodine

Povidone-Iodine is reported as an ingredient of Homodon in the following countries:

• Japan

International Drug Name Search

Nerapin

Nerapin may be available in the countries listed below.

Ingredient matches for Nerapin

Nevirapine

Nevirapine is reported as an ingredient of Nerapin in the following countries:

• Argentina

International Drug Name Search

Atenolol Nordic

Atenolol Nordic may be available in the countries listed below.

Ingredient matches for Atenolol Nordic

Atenolol

Atenolol is reported as an ingredient of Atenolol Nordic in the following countries:

• Sweden

International Drug Name Search

Norfloxacine-Sandoz

Norfloxacine-Sandoz may be available in the countries listed below.

Ingredient matches for Norfloxacine-Sandoz

Norfloxacin

Norfloxacin is reported as an ingredient of Norfloxacine-Sandoz in the following countries:

• France


• Luxembourg


• Netherlands

International Drug Name Search

Pakurat

Pakurat may be available in the countries listed below.

Ingredient matches for Pakurat

Ibuprofen

Ibuprofen is reported as an ingredient of Pakurat in the following countries:

• Argentina

International Drug Name Search

Para-z-mol

Para-z-mol may be available in the countries listed below.

Ingredient matches for Para-z-mol

Paracetamol

Paracetamol is reported as an ingredient of Para-z-mol in the following countries:

• Argentina

International Drug Name Search

Robafen Cough

Generic Name: dextromethorphan (Oral route)

dex-troe-meth-OR-fan

Commonly used brand name(s)

In the U.S.

• Babee Cof Syrup


• Benylin Pediatric Formula


• Children's Pedia Care


• Creomulsion


• Creo-Terpin


• Delsym


• Dexalone


• ElixSure Cough Children's


• Father John's Medicine


• Miltuss


• Nycoff


• Pediacare


• Pediacare Long-Acting Cough


• Robafen Cough


• Robitussin


• Silphen DM


• Simply Cough


• St. Joseph


• Vicks 44 Cough Relief

Available Dosage Forms:

• Suspension, Extended Release


• Solution


• Capsule


• Syrup


• Lozenge/Troche


• Elixir


• Liquid


• Tablet


• Capsule, Liquid Filled


• Suspension

Therapeutic Class: Antitussive

Uses For Robafen Cough

Dextromethorphan is used to relieve coughs due to colds or influenza (flu). It should not be used for chronic cough that occurs with smoking, asthma, or emphysema or when there is an unusually large amount of mucus or phlegm (flem) with the cough.

Dextromethorphan relieves cough by acting directly on the cough center in the brain.

This medicine is available without a prescription.

Do not give any over-the-counter (OTC) cough and cold medicine to a baby or child under 4 years of age. Using these medicines in very young children might cause serious or possibly life-threatening side effects .

Before Using Robafen Cough

In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:

Allergies

Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

Pediatric

Although there is no specific information comparing use of dextromethorphan in children with use in other age groups, this medicine is not expected to cause different side effects or problems in children 4 years of age and older than it does in adults.

Do not give any over-the-counter (OTC) cough and cold medicine to a baby or child under 4 years of age. Using these medicines in very young children might cause serious or possibly life-threatening side effects .

Geriatric

Many medicines have not been studied specifically in older people. Therefore, it may not be known whether they work exactly the same way they do in younger adults or if they cause different side effects or problems in older people. There is no specific information comparing use of dextromethorphan in the elderly with use in other age groups.

Breast Feeding

Studies in women suggest that this medication poses minimal risk to the infant when used during breastfeeding.

Interactions with Medicines

Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking this medicine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.

Using this medicine with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the other medicines you take.

• Clorgyline


• Iproniazid


• Isocarboxazid


• Moclobemide


• Nialamide


• Pargyline


• Phenelzine


• Procarbazine


• Rasagiline


• Selegiline


• Toloxatone


• Tranylcypromine

Using this medicine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.

• Abiraterone


• Amitriptyline


• Amoxapine


• Citalopram


• Clomipramine


• Desipramine


• Desvenlafaxine


• Doxepin


• Duloxetine


• Escitalopram


• Fluoxetine


• Fluvoxamine


• Imipramine


• Linezolid


• Milnacipran


• Nortriptyline


• Paroxetine


• Protriptyline


• Sertraline


• Sibutramine


• Trimipramine


• Venlafaxine

Using this medicine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.

• Clobazam


• Haloperidol


• Quinidine


• Vemurafenib

Interactions with Food/Tobacco/Alcohol

Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.

Other Medical Problems

The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:

• Asthma—Since dextromethorphan decreases coughing, it makes it difficult to get rid of the mucus that collects in the lungs and airways during asthma

• Diabetes (sugar diabetes)—Some products contain sugar and may affect control of blood glucose monitoring

• Liver disease—Dextromethorphan may build up in the body and cause unwanted effects

• Chronic bronchitis or


• Emphysema or


• Mucus or phlegm with cough—Since dextromethorphan decreases coughing, it makes it difficult to get rid of the mucus that may collect in the lungs and airways with some diseases

• Slowed breathing—Dextromethorphan may slow the rate of breathing even further

Proper Use of dextromethorphan

This section provides information on the proper use of a number of products that contain dextromethorphan. It may not be specific to Robafen Cough. Please read with care.

Make certain your health care professional knows if you are on a low-sodium, low-sugar, or any other special diet. Most medicines contain more than their active ingredient, and many liquid medicines contain alcohol.

Use this medicine only as directed by your doctor or the directions on the label. Do not use more of it, do not use it more often, and do not use it for a longer time than your doctor or the label says. Although this effect has happened only rarely, dextromethorphan has become habit-forming (causing mental or physical dependence) in some persons who used too much for a long time.

Dosing

The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.

The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.

• For lozenge dosage form:
  
  • For cough:
    
    • Adults and children 12 years of age and older—5 to 15 mg every two to four hours, as needed.
    
    
    • Children 6 to 12 years of age—5 to 15 mg every two to six hours, as needed.
    
    
    • Children 4 to 6 years of age—5 mg every four hours, as needed.
    
    
    • Children and infants up to 4 years of age—Use is not recommended .
    
    
  
  


• For syrup dosage form:
  
  • For cough:
    
    • Adults and children 12 years of age and older—30 mg every six to eight hours, as needed.
    
    
    • Children 6 to 12 years of age—7 mg every four hours or 15 mg every six to eight hours, as needed.
    
    
    • Children 4 to 6 years of age—3.5 mg every four hours or 7.5 mg every six to eight hours, as needed.
    
    
    • Children and infants up to 4 years of age—Use is not recommended .
    
    
  
  


• For extended-release oral suspension dosage form :
  
  • For cough:
    
    • Adults and children 12 years of age and older—60 mg every twelve hours, as needed.
    
    
    • Children 6 to 12 years of age—30 mg every twelve hours, as needed.
    
    
    • Children 4 to 6 years of age—15 mg every twelve hours, as needed.
    
    
    • Children and infants up to 4 years of age—Use is not recommended .
    
    
  
  

Missed Dose

If you miss a dose of this medicine, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.

Storage

Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.

Keep out of the reach of children.

Do not keep outdated medicine or medicine no longer needed.

Precautions While Using Robafen Cough

If your cough has not improved after 7 days, if sore throat has not improved after 2 days, if you have a high fever, skin rash, or continuing headache with the cough, or if asthma or high blood pressure is present, check with your doctor. These signs may mean that you have other medical problems.

Dissolve lozenges in the mouth with caution, to lessen the risk of choking.

Robafen Cough Side Effects

Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor as soon as possible if any of the following side effects occur:

Symptoms of overdose

• Blurred vision


• confusion


• difficulty in urination


• drowsiness or dizziness


• nausea or vomiting (severe)


• shakiness and unsteady walk


• slowed breathing


• unusual excitement, nervousness, restlessness, or irritability (severe)

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Less common or rare

• Confusion


• constipation


• dizziness (mild)


• drowsiness (mild)


• headache


• nausea or vomiting


• stomach pain

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: Robafen Cough side effects (in more detail)

The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.

The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.

More Robafen Cough resources

• Robafen Cough Side Effects (in more detail)
• Robafen Cough Use in Pregnancy & Breastfeeding
• Robafen Cough Drug Interactions
• Robafen Cough Support Group
• 8 Reviews for Robafen Cough - Add your own review/rating

Compare Robafen Cough with other medications

• Cough

Cardomine

Cardomine may be available in the countries listed below.

Ingredient matches for Cardomine

Molsidomine

Molsidomine is reported as an ingredient of Cardomine in the following countries:

• Tunisia

International Drug Name Search

Panvermin

Panvermin may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Panvermin

Levamisole

Levamisole hydrochloride (a derivative of Levamisole) is reported as an ingredient of Panvermin in the following countries:

• Portugal

International Drug Name Search

Sedulin

Sedulin may be available in the countries listed below.

Ingredient matches for Sedulin

Diazepam

Diazepam is reported as an ingredient of Sedulin in the following countries:

• Bangladesh

International Drug Name Search

Walaphage

Walaphage may be available in the countries listed below.

Ingredient matches for Walaphage

Metformin

Metformin hydrochloride (a derivative of Metformin) is reported as an ingredient of Walaphage in the following countries:

• India

International Drug Name Search

Cibalgin

Cibalgin may be available in the countries listed below.

Ingredient matches for Cibalgin

Propyphenazone

Propyphenazone is reported as an ingredient of Cibalgin in the following countries:

• Bahrain


• Ghana


• Kenya


• Libya


• Nigeria


• Sudan


• Tanzania


• Zimbabwe

International Drug Name Search

Ammo Horse

Ammo Horse may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Ammo Horse

Abamectin

Abamectin is reported as an ingredient of Ammo Horse in the following countries:

• Australia


• New Zealand

Morantel

Morantel tartrate (a derivative of Morantel) is reported as an ingredient of Ammo Horse in the following countries:

• Australia


• New Zealand

International Drug Name Search

Carnitine Chloride

Carnitine Chloride may be available in the countries listed below.

Ingredient matches for Carnitine Chloride

Carnitine

Carnitine Chloride (JAN) is also known as Carnitine (Rec.INN)

International Drug Name Search

Glossary

JAN	Japanese Accepted Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Normotemp

Normotemp may be available in the countries listed below.

Ingredient matches for Normotemp

Paracetamol

Paracetamol is reported as an ingredient of Normotemp in the following countries:

• Ecuador

International Drug Name Search

Glitra

Glitra may be available in the countries listed below.

Ingredient matches for Glitra

Glimepiride

Glimepiride is reported as an ingredient of Glitra in the following countries:

• Tunisia

International Drug Name Search

Monocef

Monocef may be available in the countries listed below.

Ingredient matches for Monocef

Cefonicid

Cefonicid is reported as an ingredient of Monocef in the following countries:

• Israel

International Drug Name Search

Teranar

Teranar may be available in the countries listed below.

Ingredient matches for Teranar

Terazosin

Terazosin hydrochloride (a derivative of Terazosin) is reported as an ingredient of Teranar in the following countries:

• Germany

International Drug Name Search

Pentostatine

Pentostatine may be available in the countries listed below.

Ingredient matches for Pentostatine

Pentostatin

Pentostatine (DCF) is known as Pentostatin in the US.

International Drug Name Search

Glossary

DCF	Dénomination Commune Française

Click for further information on drug naming conventions and International Nonproprietary Names.

Seasonale

See also: Generic Seasonique

Seasonale is a brand name of ethinyl estradiol/levonorgestrel, approved by the FDA in the following formulation(s):

SEASONALE (ethinyl estradiol; levonorgestrel - tablet; oral)

• 
  Manufacturer: DURAMED RES
  
  Approval date: September 5, 2003
  
  Strength(s): 0.03MG;0.15MG ^[RLD][AB]

Has a generic version of Seasonale been approved?

A generic version of Seasonale has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Seasonale and have been approved by the FDA:

INTROVALE (ethinyl estradiol; levonorgestrel tablet; oral)

• 
  Manufacturer: SANDOZ
  
  Approval date: September 27, 2010
  
  Strength(s): 0.03MG;0.15MG ^[AB]

QUASENSE (ethinyl estradiol; levonorgestrel tablet; oral)

• 
  Manufacturer: WATSON LABS
  
  Approval date: September 6, 2006
  
  Strength(s): 0.03MG;0.15MG ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Seasonale. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
  Patent 5,898,032
  Issued: April 27, 1999
  Inventor(s): Hodgen; Gary D.
  Assignee(s): Medical College of Hampton Roads
  A method of female contraception involves administering a combination of estrogen and progestin for 60-110 consecutive days in which the daily amounts of estrogen and progestin are equivalent to about 5-35 mcg of ethinyl estradiol and about 0.025 to 10 mg of norethindrone acetate, respectively. The advantages include less menstrual bleeding, less patient anemia, less total exposure to medication, higher compliance rates and more lifestyle convenience for patients.
  
  Patent expiration dates:
  
  
  • June 23, 2017
    
    ✓ 
    Patent use: PREVENTION OF PREGNANCY
  
  



• 
  Methods of extended use oral contraception
  Patent RE39861
  Issued: September 25, 2007
  Inventor(s): Hodgen; Gary D.
  Assignee(s): Duramed Pharmaceuticals, Inc.
  A method of female contraception involves administering a combination of estrogen and progestin for 60-110 consecutive days in which the daily amounts of estrogen and progestin are equivalent to about 5-35 mcg of ethinyl estradiol and about 0.025 to 10 mg of norethindrone acetate, respectively. The advantages include less menstrual bleeding, less patient anemia, less total exposure to medication, higher compliance rates and more lifestyle convenience for patients.
  
  Patent expiration dates:
  
  
  • June 23, 2017
    
    ✓ 
    Patent use: PREVENTION OF PREGNANCY IN WOMEN WHO ELECT TO USE ORAL CONTRACEPTIVES AS A METHOD OF CONTRACEPTION
  
  

See also...

• Seasonale Consumer Information (Drugs.com)
• Seasonale Consumer Information (Wolters Kluwer)
• Seasonale extended-cycle Consumer Information (Cerner Multum)
• Levonorgestrel/Ethinyl Estradiol Consumer Information (Wolters Kluwer)
• Ethinyl estradiol and levonorgestrel Consumer Information (Cerner Multum)
• Ethinyl estradiol and levonorgestrel extended-cycle Consumer Information (Cerner Multum)

Prasepine

Prasepine may be available in the countries listed below.

Ingredient matches for Prasepine

Prazepam

Prazepam is reported as an ingredient of Prasepine in the following countries:

• Thailand

International Drug Name Search

Triclanil

Triclanil may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Triclanil

Triclabendazole

Triclabendazole is reported as an ingredient of Triclanil in the following countries:

• France

International Drug Name Search

Perindal

Perindal may be available in the countries listed below.

Ingredient matches for Perindal

Indapamide

Indapamide is reported as an ingredient of Perindal in the following countries:

• Bangladesh

Perindopril

Perindopril is reported as an ingredient of Perindal in the following countries:

• Bangladesh

International Drug Name Search